Home › Lung Cancer › NCT06810375
Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
RecruitingPhase 3
Who can join
Ages 18 to 90 · All sexes
Full eligibility criteria
Inclusion Criteria: * Video assisted pulmonary resection, pleurodesis or decortication Exclusion Criteria: * Allergy to local anesthetics * Patient undergoing bilateral surgery * Surgery is emergent as deemed by the principal investigator
About the study
This clinical trial compares efficacy in postoperative pain management in thoracic surgery between erector spinae block versus liposomal bupivacaine injections.
What is being tested
- Erector Spinae (ESP) Block with Bupivacaine (Marcaine®) (drug)
- Intercostal nerve block (drug)
Sponsor: George Washington University · Participants: 120 · Started: Mar 1, 2025
Contact the study team
- Eduard Shaykhinurov, MS · Phone: 2022038960
Official record on ClinicalTrials.gov — NCT06810375
Locations in the U.S.
| District of Columbia | The George Washington University Hospital, Washington D.C. |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.